Authors
BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to discuss legal issues life sciences companies face when dealing with the FDA.
Related Capabilities
Practices –
Industries –
Latest Perspectives
-
November 162023
-
October 062023
Stay up-to-date on our perspectives
Subscribe to Email